Cancer Research Cell Death Mechanisms and Cancer Therapy Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tiano, H. F.
Right arrow Articles by Langenbach, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tiano, H. F.
Right arrow Articles by Langenbach, R.
[Cancer Research 62, 3395-3401, June 15, 2002]
© 2002 American Association for Cancer Research

Carcinogenesis

Deficiency of Either Cyclooxygenase (COX)-1 or COX-2 Alters Epidermal Differentiation and Reduces Mouse Skin Tumorigenesis

Howard F. Tiano, Charles D. Loftin, Jackie Akunda, Christopher A. Lee, Judson Spalding, Alisha Sessoms, David B. Dunson, Eleanor G. Rogan, Scott G. Morham, Robert C. Smart and Robert Langenbach1

Laboratory of Experimental Carcinogenesis and Mutagenesis [H. F. T., C. D. L., J. A., C. A. L., J. S., A. S., R. L.] and Biostatistics Branch [D. B. D.], National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709; Eppley Institute for Research in Cancer and Allied Diseases, Nebraska Medical Center, Omaha, Nebraska 68198 [E. G. R.]; Myriad Genetics, Inc., Salt Lake City, Utah 84108 [S. G. M.]; and Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina 27695 [R. C. S.]

Nonsteroidal anti-inflammatory drugs are widely reported to inhibit carcinogenesis in humans and in rodents. These drugs are believed to act by inhibiting one or both of the known isoforms of cyclooxygenase (COX). However, COX-2, and not COX-1, is the isoform most frequently reported to have a key role in tumor development. Here we report that homozygous deficiency of either COX-1 or COX-2 reduces skin tumorigenesis by 75% in a multistage mouse skin model. Reduced tumorigenesis was observed even though the levels of stable 7,12-dimethylbenz(a)anthracene-DNA adducts were increased about 2-fold in the COX-deficient mice compared with wild-type mice. The premature onset of keratinocyte terminal differentiation appeared to be the cellular event leading to the reduced tumorigenesis because keratin 1 and keratin 10, two keratins that indicate the commitment of keratinocytes to differentiate, were expressed 8–13-fold and 10–20-fold more frequently in epidermal basal cells of the COX-1-deficient and COX-2-deficient mice, respectively, than in wild-type mice. Papillomas on the COX-deficient mice also displayed the premature onset of keratinocyte terminal differentiation. However, loricrin, a late marker of epidermal differentiation, was not significantly altered, suggesting that it was the early stages of keratinocyte differentiation that were primarily affected by COX deficiency. Because keratin 5, a keratin associated with basal cells, was detected differently in papillomas of COX-1-deficient as compared with COX-2-deficient mice, it appears that the isoforms do not have identical roles in papilloma development. Interestingly, apoptosis, a cellular process associated with nonsteroidal anti-inflammatory drug-induced inhibition of tumorigenesis, was not significantly altered in the epidermis or in papillomas of the COX-deficient mice. Thus, both COX-1 and COX-2 have roles in keratinocyte differentiation, and we propose that the absence of either isoform causes premature terminal differentiation of initiated keratinocytes and reduced tumor formation.




This article has been cited by other articles:


Home page
 Cancer Prevention ResearchHome page
V. D. Kekatpure, J. O. Boyle, X. K. Zhou, A. J. Duffield-Lillico, N. D. Gross, N. Y. Lee, K. Subbaramaiah, J. D. Morrow, G. Milne, S. M. Lippman, et al.
Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients
Cancer Prevention Research, November 1, 2009; 2(11): 957 - 965.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K.-S. Chun, H.-C. Lao, C. S. Trempus, M. Okada, and R. Langenbach
The prostaglandin receptor EP2 activates multiple signaling pathways and {beta}-arrestin1 complex formation during mouse skin papilloma development
Carcinogenesis, September 1, 2009; 30(9): 1620 - 1627.
[Abstract] [Full Text] [PDF]

Home page
 Vet PatholHome page
S. J. Baek, M. F. McEntee, and A. M. Legendre
REVIEW PAPER: Cancer Chemopreventive Compounds and Canine Cancer
Vet. Pathol., July 1, 2009; 46(4): 576 - 588.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Subbaramaiah, R. Benezra, C. Hudis, and A. J. Dannenberg
Cyclooxygenase-2-derived Prostaglandin E2 Stimulates Id-1 Transcription
J. Biol. Chem., December 5, 2008; 283(49): 33955 - 33968.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. T. Bility, M. K. Devlin-Durante, N. Blazanin, A. B. Glick, J. M. Ward, B. H. Kang, M. J. Kennett, F. J. Gonzalez, and J. M. Peters
Ligand activation of peroxisome proliferator-activated receptor {beta}/{delta} (PPAR{beta}/{delta}) inhibits chemically induced skin tumorigenesis
Carcinogenesis, December 1, 2008; 29(12): 2406 - 2414.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. R. Howe and S. M. Lippman
Modulation of Breast Cancer Risk by Nonsteroidal Anti-inflammatory Drugs
J Natl Cancer Inst, October 15, 2008; 100(20): 1420 - 1423.
[Full Text] [PDF]

Home page
 Mol Cancer ResHome page
K. M. Ansari, J. E. Rundhaug, and S. M. Fischer
Multiple Signaling Pathways Are Responsible for Prostaglandin E2-Induced Murine Keratinocyte Proliferation
Mol. Cancer Res., June 1, 2008; 6(6): 1003 - 1016.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. Gebhardt, A. Riehl, M. Durchdewald, J. Nemeth, G. Furstenberger, K. Muller-Decker, A. Enk, B. Arnold, A. Bierhaus, P. P. Nawroth, et al.
RAGE signaling sustains inflammation and promotes tumor development
J. Exp. Med., February 18, 2008; 205(2): 275 - 285.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J.-C. Lee, J. K. Kundu, D.-M. Hwang, H.-K. Na, and Y.-J. Surh
Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-{kappa}B and AP-1: I{kappa}B kinase and c-Jun-N-terminal kinase as respective potential upstream targets
Carcinogenesis, July 1, 2007; 28(7): 1491 - 1498.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. J. Roberts, B. Y. Ng, R. B. Filler, J. Lewis, E. J. Glusac, A. C. Hayday, R. E. Tigelaar, and M. Girardi
Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis
PNAS, April 17, 2007; 104(16): 6770 - 6775.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Subbaramaiah and A. J. Dannenberg
Cyclooxygenase-2 Transcription Is Regulated by Human Papillomavirus 16 E6 and E7 Oncoproteins: Evidence of a Corepressor/Coactivator Exchange
Cancer Res., April 15, 2007; 67(8): 3976 - 3985.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D.-M. Hwang, J. K. Kundu, J.-W. Shin, J.-C. Lee, H. J. Lee, and Y.-J. Surh
cis-9,trans-11-Conjugated linoleic acid down-regulates phorbol ester-induced NF-{kappa}B activation and subsequent COX-2 expression in hairless mouse skin by targeting I{kappa}B kinase and PI3K-Akt
Carcinogenesis, February 1, 2007; 28(2): 363 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Ponthan, M. Wickstrom, H. Gleissman, O. M. Fuskevag, L. Segerstrom, B. Sveinbjornsson, C. P.F. Redfern, S. Eksborg, P. Kogner, and J. I. Johnsen
Celecoxib Prevents Neuroblastoma Tumor Development and Potentiates the Effect of Chemotherapeutic Drugs In vitro and In vivo
Clin. Cancer Res., February 1, 2007; 13(3): 1036 - 1044.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Yu, J. Fan, Y. Hui, C. A. Rouzer, L. J. Marnett, A. J. Klein-Szanto, G. A. FitzGerald, and C. D. Funk
Targeted Cyclooxygenase Gene (Ptgs) Exchange Reveals Discriminant Isoform Functionality
J. Biol. Chem., January 12, 2007; 282(2): 1498 - 1506.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
X. Tong, R. T. Van Dross, A. Abu-Yousif, A. R. Morrison, and J. C. Pelling
Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition
Mol. Cell. Biol., January 1, 2007; 27(1): 283 - 296.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
W.-C. Tsai, S.-T. Tsai, Y.-T. Jin, and L.-W. Wu
Cyclooxygenase-2 Is Involved in S100A2-Mediated Tumor Suppression in Squamous Cell Carcinoma
Mol. Cancer Res., August 1, 2006; 4(8): 539 - 547.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. K. Kundu, Y. K. Shin, S. H. Kim, and Y.-J. Surh
Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-{kappa}B in mouse skin by blocking I{kappa}B kinase activity
Carcinogenesis, July 1, 2006; 27(7): 1465 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. J. Kim, K.S. Prabhu, F. J. Gonzalez, and J. M. Peters
Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta})
Carcinogenesis, May 1, 2006; 27(5): 1105 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
K. W. Lee, J. K. Kundu, S. O. Kim, K.-S. Chun, H. J. Lee, and Y.-J. Surh
Cocoa Polyphenols Inhibit Phorbol Ester-Induced Superoxide Anion Formation in Cultured HL-60 Cells and Expression of Cyclooxygenase-2 and Activation of NF-{kappa}B and MAPKs in Mouse Skin In Vivo
J. Nutr., May 1, 2006; 136(5): 1150 - 1155.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
O. Millan, D. Rico, H. Peinado, N. Zarich, K. Stamatakis, D. Perez-Sala, J. M. Rojas, A. Cano, and L. Bosca
Potentiation of tumor formation by topical administration of 15-deoxy-{Delta}12,14-prostaglandin J2 in a model of skin carcinogenesis
Carcinogenesis, February 1, 2006; 27(2): 328 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. J. Stout, D. Westdijk, D. M. Calkhoven, O. Pijper, C. M. P. Backendorf, R. Willemze, L. H. F. Mullenders, and F. R. de Gruijl
Epidermal transit of replication-arrested, undifferentiated keratinocytes in UV-exposed XPC mice: An alternative to in situ apoptosis
PNAS, December 27, 2005; 102(52): 18980 - 18985.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. R. Howe, S.-H. Chang, K. C. Tolle, R. Dillon, L. J.T. Young, R. D. Cardiff, R. A. Newman, P. Yang, H. T. Thaler, W. J. Muller, et al.
HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice
Cancer Res., November 1, 2005; 65(21): 10113 - 10119.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Yamaguchi, A. Lantowski, A. J. Dannenberg, and K. Subbaramaiah
Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2
J. Biol. Chem., September 23, 2005; 280(38): 32569 - 32577.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. D. Stoner, H. Qin, T. Chen, P. S. Carlton, M. E. Rose, R. M. Aziz, and R. Dixit
The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis
Carcinogenesis, September 1, 2005; 26(9): 1590 - 1595.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. R. Marques, J. S. Horner, R. A. Ihrie, R. T. Bronson, and L. D. Attardi
Mice Lacking the p53/p63 Target Gene Perp Are Resistant to Papilloma Development
Cancer Res., August 1, 2005; 65(15): 6551 - 6556.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. K. Altorki, J. L. Port, F. Zhang, D. Golijanin, H. T. Thaler, A. J. Duffield-Lillico, K. Subbaramaiah, and A. J. Dannenberg
Chemotherapy Induces the Expression of Cyclooxygenase-2 in Non-Small Cell Lung Cancer
Clin. Cancer Res., June 1, 2005; 11(11): 4191 - 4197.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Kampfer, R. Schmidt, G. Geisslinger, J. Pfeilschifter, and S. Frank
Wound Inflammation in Diabetic ob/ob Mice: Functional Coupling of Prostaglandin Biosynthesis to Cyclooxygenase-1 Activity in Diabetes-Impaired Wound Healing
Diabetes, May 1, 2005; 54(5): 1543 - 1551.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. R. Brown and R. N. DuBois
COX-2: A Molecular Target for Colorectal Cancer Prevention
J. Clin. Oncol., April 20, 2005; 23(12): 2840 - 2855.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. D. Klein, C. S. Van Pelt, A. L. Sabichi, J. dela Cerda, S. M. Fischer, G. Furstenberger, and K. Muller-Decker
Transitional Cell Hyperplasia and Carcinomas in Urinary Bladders of Transgenic Mice with Keratin 5 Promoter-Driven Cyclooxygenase-2 Overexpression
Cancer Res., March 1, 2005; 65(5): 1808 - 1813.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. I. Patel, K. Subbaramaiah, B. Du, M. Chang, P. Yang, R. A. Newman, C. Cordon-Cardo, H. T. Thaler, and A. J. Dannenberg
Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism
Clin. Cancer Res., March 1, 2005; 11(5): 1999 - 2007.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
M. A. Bachelor, S. J. Cooper, E. T. Sikorski, and G. T. Bowden
Inhibition of p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Decreases UVB-Induced Activator Protein-1 and Cyclooxygenase-2 in a SKH-1 Hairless Mouse Model
Mol. Cancer Res., February 1, 2005; 3(2): 90 - 99.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Muller-Decker, I. Berger, K. Ackermann, V. Ehemann, S. Zoubova, S. Aulmann, W. Pyerin, and G. Furstenberger
Cystic Duct Dilatations and Proliferative Epithelial Lesions in Mouse Mammary Glands upon Keratin 5 Promoter-Driven Overexpression of Cyclooxygenase-2
Am. J. Pathol., February 1, 2005; 166(2): 575 - 584.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. J. Baek, J.-S. Kim, S. M. Moore, S.-H. Lee, J. Martinez, and T. E. Eling
Cyclooxygenase Inhibitors Induce the Expression of the Tumor Suppressor Gene EGR-1, Which Results in the Up-Regulation of NAG-1, an Antitumorigenic Protein
Mol. Pharmacol., February 1, 2005; 67(2): 356 - 364.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Moraitis, B. Du, M. S. De Lorenzo, J. O. Boyle, B. B. Weksler, E. G. Cohen, J. F. Carew, N. K. Altorki, L. Kopelovich, K. Subbaramaiah, et al.
Levels of Cyclooxygenase-2 Are Increased in the Oral Mucosa of Smokers: Evidence for the Role of Epidermal Growth Factor Receptor and Its Ligands
Cancer Res., January 15, 2005; 65(2): 664 - 670.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Matsumura, A. M. Moodycliffe, D. X. Nghiem, S. E. Ullrich, and H. N. Ananthaswamy
Resistance of CD1d-/- Mice to Ultraviolet-Induced Skin Cancer Is Associated with Increased Apoptosis
Am. J. Pathol., September 1, 2004; 165(3): 879 - 887.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. P. Pentland, G. Scott, J. VanBuskirk, C. Tanck, G. LaRossa, and S. Brouxhon
Cyclooxygenase-1 Deletion Enhances Apoptosis but Does Not Protect Against Ultraviolet Light-Induced Tumors
Cancer Res., August 15, 2004; 64(16): 5587 - 5591.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Gupta, V. M. Adhami, M. Subbarayan, G. T. MacLennan, J. S. Lewin, U. O. Hafeli, P. Fu, and H. Mukhtar
Suppression of Prostate Carcinogenesis by Dietary Supplementation of Celecoxib in Transgenic Adenocarcinoma of the Mouse Prostate Model
Cancer Res., May 1, 2004; 64(9): 3334 - 3343.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
F. G. Bottone Jr, J. M. Martinez, B. Alston-Mills, and T. E. Eling
Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells
Carcinogenesis, March 1, 2004; 25(3): 349 - 357.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Golijanin, J.-Y. Tan, A. Kazior, E. G. Cohen, P. Russo, G. Dalbagni, K. J. Auborn, K. Subbaramaiah, and A. J. Dannenberg
Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Are Overexpressed in Squamous Cell Carcinoma of the Penis
Clin. Cancer Res., February 1, 2004; 10(3): 1024 - 1031.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. K. Kundu, H.-K. Na, K.-S. Chun, Y.-K. Kim, S. J. Lee, S. S. Lee, O.-S. Lee, Y.-C. Sim, and Y.-J. Surh
Inhibition of Phorbol Ester-Induced COX-2 Expression by Epigallocatechin Gallate in Mouse Skin and Cultured Human Mammary Epithelial Cells
J. Nutr., November 1, 2003; 133(11): 3805S - 3810.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. S. De Lorenzo, K. Yamaguchi, K. Subbaramaiah, and A. J. Dannenberg
Bryostatin-1 Stimulates the Transcription of Cyclooxygenase-2: Evidence for an Activator Protein-1-Dependent Mechanism
Clin. Cancer Res., October 15, 2003; 9(13): 5036 - 5043.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Subbaramaiah, T. P. Marmo, D. A. Dixon, and A. J. Dannenberg
Regulation of Cyclooxgenase-2 mRNA Stability by Taxanes: EVIDENCE FOR INVOLVEMENT OF p38, MAPKAPK-2, and HuR
J. Biol. Chem., September 26, 2003; 278(39): 37637 - 37647.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Takeda, M. Sonoshita, H. Oshima, K.-i. Sugihara, P. C. Chulada, R. Langenbach, M. Oshima, and M. M. Taketo
Cooperation of Cyclooxygenase 1 and Cyclooxygenase 2 in Intestinal Polyposis
Cancer Res., August 15, 2003; 63(16): 4872 - 4877.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N.K. Altorki, R.S. Keresztes, J.L. Port, D.M. Libby, R.J. Korst, D.B. Flieder, C.A. Ferrara, D.F. Yankelevitz, K. Subbaramaiah, M.W. Pasmantier, et al.
Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non-Small-Cell Lung Cancer
J. Clin. Oncol., July 15, 2003; 21(14): 2645 - 2650.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. Klatt and M. Serrano
Engineering cancer resistance in mice
Carcinogenesis, May 1, 2003; 24(5): 817 - 826.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Muller-Decker, G. Neufang, I. Berger, M. Neumann, F. Marks, and G. Furstenberger
Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis
PNAS, September 17, 2002; 99(19): 12483 - 12488.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.